Form 4: Juan R. Luciano Acquires Eli Lilly & Co Stock Through Directors' Deferral Plan

Director Juan R. Luciano acquired 19.644 shares of Eli Lilly & Co (LLY) common stock on May 19, 2025, through the Lilly Directors' Deferral Plan.

Summary

• On May 19, 2025, Juan R. Luciano, a director of Eli Lilly & Co, acquired 19.644 shares of common stock.
• The acquisition was made through the Lilly Directors' Deferral Plan at a price of $755.11 per share.
• These shares were deferred in lieu of cash compensation and will be settled in shares of common stock following Luciano's separation from service.
• Following the transaction, Luciano directly owns 16,313.83 shares of Eli Lilly & Co.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects a director's continued investment in the company, which is generally seen as a good sign. There are no negative aspects presented in the filing.

Positives

• The acquisition reflects Luciano's continued investment in Eli Lilly & Co.
• The use of the Directors' Deferral Plan allows for tax-deferred accumulation of company stock.

Future Outlook

The acquired shares will be settled in the future upon Luciano's separation from service.

Industry Context

This filing is a routine disclosure of a director's stock acquisition, which is common for executives and board members of publicly traded companies. It reflects a continued investment in the company's stock.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it signals confidence from a company director.

Key Dates

Keywords

Eli Lilly & Co, LLY, Juan R. Luciano, Director, Stock Acquisition, Directors' Deferral Plan, Form 4, Beneficial Ownership